vs
Side-by-side financial comparison of Dole plc (DOLE) and SELECT MEDICAL HOLDINGS CORP (SEM). Click either name above to swap in a different company.
Dole plc is the larger business by last-quarter revenue ($2.3B vs $1.4B, roughly 1.6× SELECT MEDICAL HOLDINGS CORP). SELECT MEDICAL HOLDINGS CORP runs the higher net margin — 1.4% vs 0.2%, a 1.2% gap on every dollar of revenue. On growth, Dole plc posted the faster year-over-year revenue change (10.5% vs 6.4%). Dole plc produced more free cash flow last quarter ($66.5M vs $5.2M). Over the past eight quarters, Dole plc's revenue compounded faster (3.2% CAGR vs 2.8%).
Dole plc is an Irish-American agricultural multinational corporation headquartered in Dublin, Ireland. The company is among the world's largest producers of fruit and vegetables, operating with 38,500 full-time and seasonal employees who supply some 300 products in 75 countries. Dole reported 2021 revenues of $6.5 billion.
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
DOLE vs SEM — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.3B | $1.4B |
| Net Profit | $5.1M | $20.2M |
| Gross Margin | 6.8% | — |
| Operating Margin | 1.1% | 4.6% |
| Net Margin | 0.2% | 1.4% |
| Revenue YoY | 10.5% | 6.4% |
| Net Profit YoY | -64.6% | 225.7% |
| EPS (diluted) | $0.05 | $0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $1.4B | ||
| Q3 25 | $2.3B | $1.4B | ||
| Q2 25 | $2.4B | $1.3B | ||
| Q1 25 | $2.1B | $1.4B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | $2.1B | $1.3B | ||
| Q2 24 | $2.1B | $1.3B | ||
| Q1 24 | $2.1B | $1.3B |
| Q4 25 | — | $20.2M | ||
| Q3 25 | $5.1M | $28.8M | ||
| Q2 25 | $10.0M | $40.6M | ||
| Q1 25 | $38.9M | $56.7M | ||
| Q4 24 | — | $-16.1M | ||
| Q3 24 | $14.4M | $55.6M | ||
| Q2 24 | $80.1M | $77.6M | ||
| Q1 24 | $70.1M | $96.9M |
| Q4 25 | — | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | 9.0% | — | ||
| Q1 25 | 8.7% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 8.0% | — | ||
| Q2 24 | 9.4% | — | ||
| Q1 24 | 9.2% | — |
| Q4 25 | — | 4.6% | ||
| Q3 25 | 1.1% | 5.4% | ||
| Q2 25 | 4.3% | 6.5% | ||
| Q1 25 | 3.2% | 8.3% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | 2.3% | 4.3% | ||
| Q2 24 | 4.0% | 5.8% | ||
| Q1 24 | 5.3% | 9.0% |
| Q4 25 | — | 1.4% | ||
| Q3 25 | 0.2% | 2.1% | ||
| Q2 25 | 0.4% | 3.0% | ||
| Q1 25 | 1.9% | 4.2% | ||
| Q4 24 | — | -1.2% | ||
| Q3 24 | 0.7% | 4.4% | ||
| Q2 24 | 3.8% | 6.1% | ||
| Q1 24 | 3.3% | 7.3% |
| Q4 25 | — | $0.17 | ||
| Q3 25 | $0.05 | $0.23 | ||
| Q2 25 | $0.10 | $0.32 | ||
| Q1 25 | $0.41 | $0.44 | ||
| Q4 24 | — | $-0.12 | ||
| Q3 24 | $0.15 | $0.43 | ||
| Q2 24 | $0.84 | $0.60 | ||
| Q1 24 | $0.74 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $321.0M | $26.5M |
| Total DebtLower is stronger | — | $1.8B |
| Stockholders' EquityBook value | $1.4B | $1.7B |
| Total Assets | $4.5B | $5.9B |
| Debt / EquityLower = less leverage | — | 1.06× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $26.5M | ||
| Q3 25 | $321.0M | $60.1M | ||
| Q2 25 | $323.1M | $52.3M | ||
| Q1 25 | $261.0M | $53.2M | ||
| Q4 24 | — | $59.7M | ||
| Q3 24 | $266.4M | $191.5M | ||
| Q2 24 | $225.8M | $111.2M | ||
| Q1 24 | $245.5M | $92.6M |
| Q4 25 | — | $1.8B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | — | $1.8B | ||
| Q1 25 | — | $1.8B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $3.1B | ||
| Q2 24 | — | $3.6B | ||
| Q1 24 | — | $3.8B |
| Q4 25 | — | $1.7B | ||
| Q3 25 | $1.4B | $1.7B | ||
| Q2 25 | $1.4B | $1.7B | ||
| Q1 25 | $1.3B | $1.7B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | $1.4B | $1.9B | ||
| Q2 24 | $1.4B | $1.4B | ||
| Q1 24 | $1.3B | $1.4B |
| Q4 25 | — | $5.9B | ||
| Q3 25 | $4.5B | $5.7B | ||
| Q2 25 | $4.7B | $5.7B | ||
| Q1 25 | $4.5B | $5.7B | ||
| Q4 24 | — | $5.6B | ||
| Q3 24 | $4.5B | $8.0B | ||
| Q2 24 | $4.4B | $7.9B | ||
| Q1 24 | $4.5B | $7.9B |
| Q4 25 | — | 1.06× | ||
| Q3 25 | — | 1.03× | ||
| Q2 25 | — | 1.10× | ||
| Q1 25 | — | 1.03× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.62× | ||
| Q2 24 | — | 2.54× | ||
| Q1 24 | — | 2.75× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $87.4M | $64.3M |
| Free Cash FlowOCF − Capex | $66.5M | $5.2M |
| FCF MarginFCF / Revenue | 2.9% | 0.4% |
| Capex IntensityCapex / Revenue | 0.9% | 4.2% |
| Cash ConversionOCF / Net Profit | 17.12× | 3.19× |
| TTM Free Cash FlowTrailing 4 quarters | $13.7M | $117.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $64.3M | ||
| Q3 25 | $87.4M | $175.3M | ||
| Q2 25 | $18.3M | $110.3M | ||
| Q1 25 | $-78.8M | $-3.5M | ||
| Q4 24 | — | $125.4M | ||
| Q3 24 | $101.0M | $181.0M | ||
| Q2 24 | $40.2M | $278.2M | ||
| Q1 24 | $-35.0M | $-66.7M |
| Q4 25 | — | $5.2M | ||
| Q3 25 | $66.5M | $122.2M | ||
| Q2 25 | $-1.0M | $45.6M | ||
| Q1 25 | $-131.6M | $-55.8M | ||
| Q4 24 | — | $62.0M | ||
| Q3 24 | $79.9M | $130.3M | ||
| Q2 24 | $22.8M | $222.6M | ||
| Q1 24 | $-53.2M | $-119.2M |
| Q4 25 | — | 0.4% | ||
| Q3 25 | 2.9% | 9.0% | ||
| Q2 25 | -0.0% | 3.4% | ||
| Q1 25 | -6.3% | -4.1% | ||
| Q4 24 | — | 4.7% | ||
| Q3 24 | 3.9% | 10.2% | ||
| Q2 24 | 1.1% | 17.4% | ||
| Q1 24 | -2.5% | -9.0% |
| Q4 25 | — | 4.2% | ||
| Q3 25 | 0.9% | 3.9% | ||
| Q2 25 | 0.8% | 4.8% | ||
| Q1 25 | 2.5% | 3.9% | ||
| Q4 24 | — | 4.8% | ||
| Q3 24 | 1.0% | 4.0% | ||
| Q2 24 | 0.8% | 4.3% | ||
| Q1 24 | 0.9% | 4.0% |
| Q4 25 | — | 3.19× | ||
| Q3 25 | 17.12× | 6.09× | ||
| Q2 25 | 1.84× | 2.72× | ||
| Q1 25 | -2.02× | -0.06× | ||
| Q4 24 | — | — | ||
| Q3 24 | 7.01× | 3.25× | ||
| Q2 24 | 0.50× | 3.59× | ||
| Q1 24 | -0.50× | -0.69× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DOLE
Segment breakdown not available.
SEM
| Critical Illness Recovery Hospitals | $629.7M | 45% |
| Health Care Patient Service Non Medicare | $428.6M | 31% |
| Rehabilitation Hospitals | $339.2M | 24% |
